Neonatal and adult cardiovascular pathophysiological remodeling and repair: developmental role of periostin.

作者: Russell A. Norris , Thomas K. Borg , Jonathan T. Butcher , Troy A. Baudino , Indroneal Banerjee

DOI: 10.1196/ANNALS.1420.005

关键词: Cellular differentiationInternal medicineMesenchymal stem cellEndocrinologyEmbryonic stem cellPeriostinMatricellular proteinFibrosisProgenitor cellFibroblastCell biologyBiology

摘要: The neonatal heart undergoes normal hypertrophy or compensation to complete development and adapt increased systolic pressures. Hypertrophy wall stiffness are associated with a doubling of the number fibroblasts de novo formation collagen. Normal postnatal remodeling is completed within 3-4 weeks after birth but can be rekindled in adult life response environmental signals that lead pathological hypertrophy, fibrosis, failure. trigger fibroblast collagen (fibrosis) as well origin differentiation cardiac lineage not understood. Using mice studies single-cell engraftment model, we have shown derived from two extracardiac sources: embryonic proepicardial organ recruitment circulating bone marrow cells hematopoietic stem cell origin. Periostin, matricellular protein, normally expressed differentiating its expression elevated several fold Our hypothesis periostin profibrogenic (i.e., it promotes progenitor mesenchymal into their secretion compaction collagen) was tested using isolated cultured embryonic, neonatal, wild-type periostin-null, nonmyocyte populations. findings indicate abrogation by targeted gene deletion inhibits permits misdirection cardiomyocyte lineage. However, if forced express periostin, they became fibroblasts. Periostin plays significant role promoting fibrogenesis residual stress, tensile testings indicated played an essential regulatory maintaining biomechanical properties myocardium. These protein fibrogenesis, cardiomyocytes, for

参考文章(51)
Borg Tk, Moslehy Fa, Caulfield Jb, Ranson Wf, Structural basis of ventricular stiffness. Laboratory Investigation. ,vol. 44, pp. 49- 54 ,(1981)
Donald Orlic, Jan Kajstura, Stefano Chimenti, Igor Jakoniuk, Stacie M. Anderson, Baosheng Li, James Pickel, Ronald McKay, Bernardo Nadal-Ginard, David M. Bodine, Annarosa Leri, Piero Anversa, Bone marrow cells regenerate infarcted myocardium Nature. ,vol. 410, pp. 701- 705 ,(2001) , 10.1038/35070587
R. P VISCONTI, R. R MARKWALD, Recruitment of new cells into the postnatal heart: potential modification of phenotype by periostin. Annals of the New York Academy of Sciences. ,vol. 1080, pp. 19- 33 ,(2006) , 10.1196/ANNALS.1380.003
S Takeshita, R Kikuno, K Tezuka, E Amann, Osteoblast-specific factor 2: cloning of a putative bone adhesion protein with homology with the insect protein fasciclin I. Biochemical Journal. ,vol. 294, pp. 271- 278 ,(1993) , 10.1042/BJ2940271
Leonard M. Eisenberg, Roger R. Markwald, Cellular recruitment and the development of the myocardium. Developmental Biology. ,vol. 274, pp. 225- 232 ,(2004) , 10.1016/J.YDBIO.2004.07.023
Naruto Katsuragi, Ryuichi Morishita, Noriko Nakamura, Tayehito Ochiai, Yoshiaki Taniyama, Yasuhiro Hasegawa, Kayoko Kawashima, Yasufumi Kaneda, Toshio Ogihara, Keijiro Sugimura, Periostin as a Novel Factor Responsible for Ventricular Dilation Circulation. ,vol. 110, pp. 1806- 1813 ,(2004) , 10.1161/01.CIR.0000142607.33398.54
Kazuma Iekushi, Yoshiaki Taniyama, Junya Azuma, Naruto Katsuragi, Norio Dosaka, Fumihiro Sanada, Nobutaka Koibuchi, Kaori Nagao, Toshio Ogihara, Ryuichi Morishita, Novel Mechanisms of Valsartan on the Treatment of Acute Myocardial Infarction Through Inhibition of the Antiadhesion Molecule Periostin Hypertension. ,vol. 49, pp. 1409- 1414 ,(2007) , 10.1161/HYPERTENSIONAHA.106.080994
I. BANERJEE, K. YEKKALA, T. K BORG, T. A BAUDINO, Dynamic Interactions between Myocytes, Fibroblasts, and Extracellular Matrix Annals of the New York Academy of Sciences. ,vol. 1080, pp. 76- 84 ,(2006) , 10.1196/ANNALS.1380.007